chr22-49903787-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_024105.4(ALG12):c.*51A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.241 in 1,578,790 control chromosomes in the GnomAD database, including 58,813 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.36 ( 13931 hom., cov: 33)
Exomes 𝑓: 0.23 ( 44882 hom. )
Consequence
ALG12
NM_024105.4 3_prime_UTR
NM_024105.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.243
Genes affected
ALG12 (HGNC:19358): (ALG12 alpha-1,6-mannosyltransferase) This gene encodes a member of the glycosyltransferase 22 family. The encoded protein catalyzes the addition of the eighth mannose residue in an alpha-1,6 linkage onto the dolichol-PP-oligosaccharide precursor (dolichol-PP-Man(7)GlcNAc(2)) required for protein glycosylation. Mutations in this gene have been associated with congenital disorder of glycosylation type Ig (CDG-Ig)characterized by abnormal N-glycosylation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 22-49903787-T-C is Benign according to our data. Variant chr22-49903787-T-C is described in ClinVar as [Benign]. Clinvar id is 342038.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-49903787-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.723 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALG12 | NM_024105.4 | c.*51A>G | 3_prime_UTR_variant | 10/10 | ENST00000330817.11 | NP_077010.1 | ||
ALG12 | XM_017028936.2 | c.1238+392A>G | intron_variant | XP_016884425.1 | ||||
ALG12 | XM_017028937.2 | c.1238+392A>G | intron_variant | XP_016884426.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG12 | ENST00000330817.11 | c.*51A>G | 3_prime_UTR_variant | 10/10 | 1 | NM_024105.4 | ENSP00000333813 | P1 | ||
ENST00000610245.1 | n.1560T>C | non_coding_transcript_exon_variant | 1/1 | |||||||
ALG12 | ENST00000486602.1 | c.539A>G | p.His180Arg | missense_variant | 4/4 | 3 | ENSP00000420630 |
Frequencies
GnomAD3 genomes AF: 0.358 AC: 54366AN: 152056Hom.: 13872 Cov.: 33
GnomAD3 genomes
AF:
AC:
54366
AN:
152056
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.254 AC: 63079AN: 248116Hom.: 10947 AF XY: 0.259 AC XY: 34851AN XY: 134810
GnomAD3 exomes
AF:
AC:
63079
AN:
248116
Hom.:
AF XY:
AC XY:
34851
AN XY:
134810
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.229 AC: 326462AN: 1426616Hom.: 44882 Cov.: 27 AF XY: 0.234 AC XY: 166766AN XY: 711634
GnomAD4 exome
AF:
AC:
326462
AN:
1426616
Hom.:
Cov.:
27
AF XY:
AC XY:
166766
AN XY:
711634
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.358 AC: 54480AN: 152174Hom.: 13931 Cov.: 33 AF XY: 0.353 AC XY: 26275AN XY: 74400
GnomAD4 genome
AF:
AC:
54480
AN:
152174
Hom.:
Cov.:
33
AF XY:
AC XY:
26275
AN XY:
74400
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1157
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 16, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
ALG12-congenital disorder of glycosylation Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at